Circulating innate lymphoid cells are unchanged in response to DAC HYP therapy
详细信息 查看全文
- 作者：Geoffrey O. Gillarda ; 1 ; geoff.gillard@biogen.com" class="auth_mail" title="E-mail the corresponding author ; Steven A. Saenzb ; 1 ; David J. Hussc ; Jason D. Fontenotc
- 关键词：Daclizumab ; Innate lymphoid cell ; ILC ; Natural killer ; NK
- 刊名：Journal of Neuroimmunology
- 出版年：2016
- 出版时间：15 May 2016
- 年：2016
- 卷：294
- 期：Complete
- 页码：41-45
- 全文大小：891 K
文摘
- •
We investigated the impact of daclizumab on circulating innate lymphoid cells in MS patients.
- •
Daclizumab therapy resulted in increased percentage and number of CD56bright NK cells.
- •
Daclizumab therapy resulted in increased percentage and number of CD56hiCD16int transitional NK cells.
- •
No significant changes in total ILCs or ILC subpopulations were observed after daclizumab treatment.